HMGB3
High mobility group protein B3
Also known as: HMG2A, HMG4, HMGB3_HUMAN, MGC90319
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15347
- Gene
- HMGB3
- Ensembl
- ENSG00000029993
- Chromosome
- X
- Canonical length
- 200 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
This gene encodes a member of a family of proteins containing one or more high mobility group DNA-binding motifs. The encoded protein plays an important role in maintaining stem cell populations, and may be aberrantly expressed in tumor cells. A mutation in this gene was associated with microphthalmia, syndromic 13. There are numerous pseudogenes of this gene on multiple chromosomes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
200 residues, UniProt reviewed canonical sequence.
>O15347|HMGB3
1 MAKGDPKKPK GKMSAYAFFV QTCREEHKKK NPEVPVNFAE FSKKCSERWK TMSGKEKSKF
61 DEMAKADKVR YDREMKDYGP AKGGKKKKDP NAPKRPPSGF FLFCSEFRPK IKSTNPGISI
121 GDVAKKLGEM WNNLNDSEKQ PYITKAAKLK EKYEKDVADY KSKGKFDGAK GPAKVARKKV
181 EEEDEEEEEE EEEEEEEEDELocalizationUniProt · AlphaFold · HPA
Whether an antibody against HMGB3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 128 nTPM
Expression across tissuesHPA
Tissue
- placenta: 128 nTPM
- liver: 91 nTPM
- bone marrow: 81 nTPM
- parathyroid gland: 80 nTPM
- thymus: 61 nTPM
- skeletal muscle: 49 nTPM
Single-cell type
- syncytiotrophoblasts: 1,665 nCPM
- extravillous trophoblasts: 1,130 nCPM
- migrating cytotrophoblasts: 938 nCPM
- oocytes: 396 nCPM
- cytotrophoblasts: 372 nCPM
- respiratory ionocytes: 282 nCPM
Immune cell
- eosinophil: 11 nTPM
- myeloid DC: 6.1 nTPM
- T-reg: 5.8 nTPM
- non-classical monocyte: 5 nTPM
- classical monocyte: 4.3 nTPM
- plasmacytoid DC: 3.1 nTPM
Brain region
- cerebral cortex: 67 nTPM
- hippocampal formation: 25 nTPM
- hypothalamus: 22 nTPM
- medulla oblongata: 21 nTPM
- thalamus: 19 nTPM
- pons: 17 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HMGB3.
Disease | AllUniProt
Conditions HMGB3 is implicated in, by any mechanism.
- Microphthalmia, syndromic, 13 (MCOPS13) MIM:300915
Disease | ImmuneIEDB
Conditions an epitope on HMGB3 was assayed in.
- systemic scleroderma B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.57
- gnomAD pLI
- 0.8
- gnomAD missense Z
- 1.78
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA geometric change
- DNA recombination
- innate immune response
- negative regulation of B cell differentiation
- negative regulation of myeloid cell differentiation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HMGB3 as an antibody target. Whether an autoantibody or antibody against HMGB3 could matter depends on whether native HMGB3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HMGB3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HMGB3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...